Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Hufnagel CA, Harvey WP. The surgical correction of aortic regurgitation: Preliminary report. Bulletin of Georgetown Univ Med Cntr 1953; 60.
Hammermeister KE, Sethi GK, Henderson WG, Oprian C, Kim T, Rahimtoola SH. A comparison of outcomes in men 11 years after heart valve replacement with a mechanical or bioprosthesis. Veterans Affairs Cooperative Study on Valvular Heart Disease. New Eng Journ Med 1993;328(18):1289–1296.
Hall KV, Kaster RL, Wolfe WG. An improved pivotal disc-type prosthesis heart valve. Oslo City J Hosp 1979;29:3–21.
Nitter-Hauge S, Abdelnoor M. Ten-year experience with the Medtronic Hall valvular prosthesis. Circulation 1989;80(Suppl):43–48.
Akins C. Long-term results with the Medtronic-Hall valvular prosthesis. Ann Thorac Surg 1996; 61:806–813.
Obadia JF, Martelloni YA, Bastien OH, Durant de Gevigney GM, et al. Long-term follow-up of small (20 and 21) Medtronic-Hall aortic valve prosthesis. Ann Thorac Surg 1997;64:421–425.
Bjork VO. A new tilting disc valve prosthesis. Scand J Thorac Cardiovasc Surg 1969;4:1–10.
Wieting DW. The Bjork-Shiley Delrin tilting disc heart valve: historical perspective, design and need for scientific analysis after 25 years. J Heart Valve Dis 1996;5(Suppl):S157–S168.
Mikaeloff P, Jegaden O, Ferrinin M, Coll-Mazzei J, et al. Prospective randomized study of St. Jude Medical versus Bjork-Shiley or Starr-Edwards 6120 valve prostheses in the mitral position. J Cardiovasc Surg 1989;30:966–975.
Flemma R, Mullen D, Kleinman L. Survival and event-free analysis of 785 patients with Bjork-Shiley spherical-disc valves at 10 to 16 years. Ann Thorac Surg 1988;45:258–265.
Birkmeyer J, Marrin C, O’Conner G. Should patients with Bjork-Shiley valves undergo prophylactic replacement? Lancet 1992;340:520.
Rodler SM, Moritz A, Schreiner W, End A, Dubsky P, Wolner E. Five-year follow-up after valve replacement with the Carbomedics bileaflet prosthesis. Ann Thorac Surg 1997;63:1018–1025.
Kazui T, Yamada O, Yamagishi M, Watanabe N, Komatsu S. Aortic valve replacement with Omniscience and Omnicarbon valves. Ann Thorac Surg 1991;52:236–244.
Kazui T, Komatsu S, Inoue N. Clinical evaluation of the Omniscience aortic disc valve prosthesis. Scand J Thorac Cardiovasc Surg 1987;21:173–188.
Jamieson W, Allen P, Miyagishima RT. Carpentier-Edwards standard porcine bioprosthesis: A first generation tissue valve with excellent longterm clinical performance. J Thorac Cardiovasc Surg 1990;99:543–561.
Jamieson WRE, Munro AI, Miyagishima RT, et al. Carpentier-Edwards standard porcine bioprosthesis: Clinical performance to seventeen years. Ann Thorac Surg 1995;60:999–1007.
Carpentier A, Dubost C, Lane E et al. Continuing improvements in valvular bioprostheses. J Thorac Cardiovasc Surg 1982;83:27–42.
Jones E, Weintraub W, Craver J. Ten-year experience with the porcine bioprosthetic valve: interrelationship of valve survival and patient survival in 1,050 valve replacements. Ann Thorac Surg 1990;49:370–384.
Aberdeen J, Corr L, Milner P, Lincoln J, Burnstock G. Marked Increases in Calcitonin Gene-Related Peptide-containing Nerves in the Developing Rat Following Long-term Sympathectomy with Guanethidine. Neuroscience 1990;35(1):175–184.
Hartz R, Fisher B, Finkelmeier B, et al. An eight year experience with porcine prosthetic cardiac valves. J Thorac Cardiovasc Surg 1986;91:910–917.
Jamieson W, Burr LH, Tyers GF, Miyagishima RT, Janusz MT, et al. Carpentier-Edwards Supraannular Porcine Bioprosthesis: Clincal Performance to Twelve Years. Ann Thorac Surg 1995;60:S235–S240.
Glower DD, White W, Hattan A, et al. Determinants of reoperation after 960 valve replacements with Carpentier-Edwards prostheses. J Thorac Cardiovasc Surg 1994;107:381–393.
Geha AS, Laks H, Stensel HC et al. Late failure of porcine valve heterografts in children. J Thorac Cardiovasc Surg 1979;78:351–364.
David T, Armstrong S, Sun Z. The Hancock II bioprosthesis at ten years. Ann Thorac Surg 1995;60:S229–S234.
Barratt-Boyes BG, Jaffe WM, Hong Ko P, Whitlock RML. The Zero Pressure Fixed Medtronic Intact Porcine Valve: An 8.5 Year Review. J Heart Valve Dis 1993;2:604–611.
Lemieux MD, Jamieson W, Landymore RW, Dumesnil JG, Metras J, Munro AI, et al. Medtronic Intact Porcine bioprosthesis: clinical performance to seven years. Ann Thorac Surg 1995;60:S258–S263.
O’Brien MF, Stafford EG, Gardner MA, Pohlner PG, Tesar P, et al. The Medtronic Intact Xenograft: an analysis of 342 patients over a seven year follow-up period. Ann Thorac Surg 1995;60:S253–S257.
Cosgrove DM, Lytle BW, Williams WG. Hemodynamic performance of the Carpentier-Edwards pericardial valve in the aortic position in vivo. Circulation 1985;72(Suppl):146.
Pellerin M, Mihaileanu S, Couetil JP, Relland J, Deloche A, et al. Carpentier-Edwards Pericardial bioprosthesis in aortic position: long term follow-up 1980 to 1994. Ann Thorac Surg 1995;60:S292–S296.
Pelletier LC, Carrier MC, Leclerc Y, Dyrda I. The Carpentier-Edwards Pericardial bioprosthesis: clinical experience with 600 patients. Ann Thorac Surg 1995;60:S297–S302.
Vitale N, Giannolo B, Nappi G, DeLuca L, Piazza L, Scardone M, Cotrufo M. Long term follow up of different models of mechanical and biological mitral prostheses. EJCTS 1995;9:181–189.
Committee on Management of Patients with Valvular Disease, Robert O. Bonow MC. ACC/ AHA Practice Guidelines: Guidelines for the Management of Patients with Valvular Disease. Circulation 1998;98:1949–1984.
Jin XY, Zhang Z, Gibson DG, Yacoub MH, Pepper JR. Effects of valve substitute on changes in left ventricular function and hypertrophy after aortic valve replacement. Ann Thorac Surg 1996;62:683–690.
Del Rizzo DF, Goldman BS, Christakis GT, Powell AF, David TE. Hemodynamic Benefits of the Toronto Stentless valve. J Thorac Cardiovasc Surg 1996;112:1431–1446.
Walther T, Weigl C, Falk V, Deigler A, Shilling L, Autschbach R, Mohr FW. Impact of stentless in comparison to conventional aortic valves on postoperative left ventricular remodeling. European Heart Journal 1997.
Orszulak TA, Schaff HV, Puga FJ, Danielson GK, Mullany CJ, et al. Event status of the Starr-Edwards Aortic Valve to 20 years: A benchmark for comparison. Ann Thorac Surg 1997;63:620–626.
Baudet E, Puel V, McBride J, Grimaud J, Roques R, et al. Long-term results of valve replacement with the St. Jude Medical Prosthesis. J Thorac Cardiovasc Surg 1995;109:858–870.
Rights and permissions
Copyright information
© 2005 Springer Science+Business Media, Inc.
About this chapter
Cite this chapter
Hopkins, R.A., Lilly, R.E., St. Louis, J. (2005). The Biological Valve Spectrum and a Rationale for Prosthetic Valve Choice. In: Cardiac Reconstructions with Allograft Tissues. Springer, New York, NY. https://doi.org/10.1007/0-387-26515-5_64
Download citation
DOI: https://doi.org/10.1007/0-387-26515-5_64
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-94962-8
Online ISBN: 978-0-387-26515-5
eBook Packages: MedicineMedicine (R0)